ロード中...
Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients
Interstitial lung disease (ILD) events have been reported in Japanese non-small-cell lung cancer (NSCLC) patients receiving EGFR tyrosine kinase inhibitors. We investigated proteomic biomarkers for mechanistic insights and improved prediction of ILD. Blood plasma was collected from 43 gefitinib-trea...
保存先:
主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Public Library of Science
2011
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3140475/ https://ncbi.nlm.nih.gov/pubmed/21799770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0022062 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|